Several matter pinch shares of Agenus Inc. (NASDAQ:AGEN) [Trend Analysis], as shares plunging -0.66% to $3.67 with a share volume of 43917. Agenus Inc. (AGEN) reported that Jean-Marie Cuillerot, M.D. was appointed Chief Medical Officer (CMO). Dr. Cuillerot initially joined Agenus in 2016 as the Vice President and Global Head of Clinical Development.”In the short period that Jean-Marie has been with Agenus he has exhibited laser focus when it comes to his vision for our clinical development path forward,” said GaroArmen, Ph.D. Chairman and CEO of Agenus.
“His drug development expertise will be key in executing the Company’s corporate mission to become a commercial organization within the next five years.”Dr. Cuillerot joined Agenus as an expert clinician in immuno-oncology drug development. His past affiliations with Merck Serono and Bristol-Myers Squibb were accompanied by important accomplishments that included the advancement of the PD-L1 antagonist antibody avelumab from first in man to regulatory filing in three and a half years. In addition, Dr. Cuillerot was a key contributor in the development and filing of Yervoy.
The stock is going forward its 52-week low with 40.44% and moving down from its 52-week high price with -51.06%. To have technical analysis views, liquidity ratio of a company was calculated 3.10. The float short ratio was 13.64%, as compared to sentiment indicator; Short Ratio was 9.97.
Shares of Chevron Corporation (NYSE:CVX) [Trend Analysis] runs in leading trade, it plunging -0.08% to traded at $111.73. The firm has price volatility of 1.56% for a week and 1.19% for a month. Its beta stands at 1.22 times. Oil and natural gas producer Chevron Corp (CVX) said that it would give its top executive fewer stock options after shareholders expressed concern about executive pay.Oil companies have been restructuring pay packages of their top management after a two-year-long slump in oil prices eroded profitability.
Chevron said on Monday the average support from shareholders for the company’s compensation package fell to 54 percent in 2016 from the 95 percent it averaged between 2011 and 2015.Stock options give employees the right to buy a specific number of shares in the future at a pre-determined price. Narrow down four to firm performance, its weekly performance was -3.09% and monthly performance was -5.16%. The stock price of CVX is moving down from its 20 days moving average with -3.72% and isolated negatively from 50 days moving average with -2.81%.